Custirsen
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Custirsen, covering 2016-10-10 to 2026-04-15. Get the full timeline:
Most recent: Clinical Trial Update: A Multinational, Randomized, Open-Label Study of Custirsen In Patients With Advanced or Metastatic (Stage IV) Non-Small Cell Lung Cancer [Phase 3]